Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Jacquelot

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|February 4, 2020
Innate Lymphoid Cells in Colorectal Cancers: A Double-Edged SwordQiutong Huang, Wang Cao, Lisa Anna Mielke, et al.
Pharmaceutics|July 29, 2023
Targeting Potential of Innate Lymphoid Cells in Melanoma and Other CancersHobin Seo, Amisha Verma, Megan Kinzel, et al.
Cancers|December 10, 2021
Immune Checkpoints and Innate Lymphoid Cells-New Avenues for Cancer ImmunotherapyNicolas Jacquelot, Maryam Ghaedi, Kathrin Warner, et al.
Frontiers in Immunology|October 22, 2025
Unspoken words: decoding the dialog between type 2 innate lymphoid cells and T cellsZahra Jamila Ikra, Qiutong Huang, Huiyang Yu, et al.
Methods in Cell Biology|June 16, 2024
Differences in intratumor innate lymphoid cell composition between orthotopic and spontaneous pancreatic mouse modelsSara Lamorte, Alisha R Elford, Douglas C Chung, et al.
Cancer Research|July 26, 2015
A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1Shin Foong Ngiow, Arabella Young, Nicolas Jacquelot, et al.
International Journal of Molecular Sciences|August 27, 2021
Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future PerspectivesNicolas Jacquelot, Cyril Seillet, Fernando Souza-Fonseca-Guimaraes, et al.
Frontiers in Immunology|June 20, 2022
Editorial: Cancer Immunotherapies: From Efficacy to Resistance MechanismsJanin Chandra, Morten Hansen, Nathalie Labarriere, et al.
International Review of Cell and Molecular Biology|May 20, 2026
Interleukin-33: A new frontier in cancer immunotherapyAmrita Kaur, Kaelie Bittorf, Ayan Chanda, et al.
Oncoimmunology|September 19, 2017
Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanomaNicolas Jacquelot, Jonathan M Pitt, David P Enot, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|February 4, 2020
Innate Lymphoid Cells in Colorectal Cancers: A Double-Edged SwordQiutong Huang, Wang Cao, Lisa Anna Mielke, et al.
Pharmaceutics|July 29, 2023
Targeting Potential of Innate Lymphoid Cells in Melanoma and Other CancersHobin Seo, Amisha Verma, Megan Kinzel, et al.
Cancers|December 10, 2021
Immune Checkpoints and Innate Lymphoid Cells-New Avenues for Cancer ImmunotherapyNicolas Jacquelot, Maryam Ghaedi, Kathrin Warner, et al.
Frontiers in Immunology|October 22, 2025
Unspoken words: decoding the dialog between type 2 innate lymphoid cells and T cellsZahra Jamila Ikra, Qiutong Huang, Huiyang Yu, et al.
Methods in Cell Biology|June 16, 2024
Differences in intratumor innate lymphoid cell composition between orthotopic and spontaneous pancreatic mouse modelsSara Lamorte, Alisha R Elford, Douglas C Chung, et al.
Cancer Research|July 26, 2015
A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1Shin Foong Ngiow, Arabella Young, Nicolas Jacquelot, et al.
International Journal of Molecular Sciences|August 27, 2021
Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future PerspectivesNicolas Jacquelot, Cyril Seillet, Fernando Souza-Fonseca-Guimaraes, et al.
Frontiers in Immunology|June 20, 2022
Editorial: Cancer Immunotherapies: From Efficacy to Resistance MechanismsJanin Chandra, Morten Hansen, Nathalie Labarriere, et al.
International Review of Cell and Molecular Biology|May 20, 2026
Interleukin-33: A new frontier in cancer immunotherapyAmrita Kaur, Kaelie Bittorf, Ayan Chanda, et al.
Oncoimmunology|September 19, 2017
Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanomaNicolas Jacquelot, Jonathan M Pitt, David P Enot, et al.
Pageof 6